Clintex CTi – Medium

Clintex CTi

Clintex CTi

·

Jan 23, 2025

Update on the Progress of the CANPAIN Clinical Trial

Brief: The main CANPAIN clinical trial’s status remains unclear and is still listed as “Unknown Status” on ClinicalTrials.gov

Update on the Progress of the CANPAIN Clinical Trial

Clintex CTi

·

Jun 11, 2024

Economics evaluation of CANPAIN Fesability Study

In October 2018, the UK’s National Institute for Health and Care Excellence (“NICE”) issued a call for evidence to evaluate the safety and…

Economics evaluation of CANPAIN Fesability Study

Clintex CTi

·

Feb 6, 2024

How CTAi fits an evolving Clinical Trials market

The global AI in clinical trials market is estimated to be worth $ 2.04 billion in 2024 and expected to grow at compounded annual growth…

How CTAi fits an evolving Clinical Trials market

Clintex CTi

·

Jan 19, 2024

ClinTex x DeSci

The scientific landscape is on the cusp of a paradigm shift. Enter Decentralised Science (DeSci), a revolutionary approach that leverages…

ClinTex x DeSci

Clintex CTi

·

Jan 5, 2024

ClinTex CTi and DeSci — The Future

Clintex CTi and DeSci both work off the idea that scientific knowledge, including clinical trial intelligence, should be accessible.

ClinTex CTi and DeSci — The Future

Clintex CTi

·

Sep 28, 2023

CTAi Beta Release Imminent

We have been working tirelessly over the previous months on the development of our groundbreaking Clintex CTAi application.

CTAi Beta Release Imminent

Clintex CTi

·

Jul 31, 2023

ClinTex Q2–2023 Update

CTAi

ClinTex Q2–2023 Update

Clintex CTi

·

Jul 13, 2023

Australian Regulator approves MDMA for PTSD treatment

Australia made history on July 1, 2023, when it became the first country in the world to prescribe MDMA and psilocybin for therapeutic use…

Australian Regulator approves MDMA for PTSD treatment

Clintex CTi

·

Apr 3, 2023

AI-based Clinical Trials market to grow by 600% before end of the decade

According to a new study from Research and Markets, the global market for AI-based clinical trial solutions for patient matching is…

AI-based Clinical Trials market to grow by 600% before end of the decade

Clintex CTi

·

Jan 16, 2023

How AI will drive success in Clinical Trials

It takes up to 15 years and an average total R&D expenditure of $1.5–2 billion USD to bring a single new drug to market. About half of this…

How AI will drive success in Clinical Trials

Clintex CTi

Clintex CTi

Clinical Trials Intelligence is a data management software solution for the clinical trials industry that leverages distributed ledger technology

Following

Help

Status

About

Careers

Press

Blog

Store

Privacy

Rules

Terms

Text to speech